Xconomy: deals News, Articles and Opinions

“deals” Archives

Entry	Author	Date	Location
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal	Frank Vinluan	12/03/19	San Francisco
Partner or Die: How to Succeed Even After the Digital Health Hype Quiets Down	Rob Coppedge	12/03/19	Seattle
Astellas Bets On Gene Therapy With $3B Audentes Acquisition Offer	Sarah de Crescenzo	12/03/19	National
Neurocrine Inks $50M Xenon Pharma Deal to Expand Into Epilepsy	Sarah de Crescenzo	12/02/19	San Diego
IFM Lands $55.5M to Launch NewCo Quattro and Discovery Incubator	Frank Vinluan	12/02/19	Boston
Biotech VC Down 20% in US as Policies Drive Away Foreign Investors, BIO Says	Dan Stanton	11/29/19	National
Ferring and Blackstone Team Up to Fund Gene Therapy Firm With $570M	Frank Vinluan	11/25/19	Boston
Five Questions With a16z’s Vijay Pande on AI and Making New Drugs	Sarah de Crescenzo	11/25/19	National
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B	Frank Vinluan	11/25/19	New York
Bio Roundup: So Long Celgene, RNAi’s Arrival, Pharma in 2020 & More	Frank Vinluan	11/22/19	National
Biopharma Execs Remain Optimistic Despite Political Headwinds	Mike Ward	11/20/19	National
Alkermes Eyes Brain Disorders and Beyond With $100M Deal for Rodin	Frank Vinluan	11/18/19	Boston
Bayer and Dewpoint Ink Deal for Drugs R&D at New Frontier of Biology	Frank Vinluan	11/14/19	Boston
Avidity Bio Adds $100M to Advance R&D of Muscle Disorder Drugs	Frank Vinluan	11/13/19	San Diego
Bio Roundup: Feds Sue Gilead, Biogen Eyes China, CRISPR’d Kidneys & More	Frank Vinluan	11/08/19	National
eGenesis Lands $100M to Advance CRISPR-ed Pig Kidney to Human Test	Frank Vinluan	11/07/19	Boston
Arkuda Unveils $44M and a Protein Restoration Approach to Dementia	Frank Vinluan	11/07/19	Boston
AstraZeneca Chooses China for R&D and AI Centers, $1B Biotech Fund	Gareth Macdonald	11/06/19	National
Biogen Adds Two More Biosimilars in $100M Deal with Samsung Bioepis	Frank Vinluan	11/06/19	Boston
Stryker Adds to Trauma & Extremities Biz With $4B Wright Medical Deal	Frank Vinluan	11/04/19	Detroit Ann Arbor
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug	Frank Vinluan	10/31/19	Boston
With Ex-Medivation Exec Hung at Helm, Nuvation Nabs $275M for Cancer	Frank Vinluan	10/28/19	New York
Bio Roundup: Biogen’s Reversal, FDA Moves Fast, a CF Cocktail & More	Sarah de Crescenzo	10/25/19	National
Backed by $50M, Verseau Launches to Reprogram Immune Cells Against Cancer	Frank Vinluan	10/21/19	Boston
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More	Frank Vinluan	10/18/19	National
Healx Bags $56M to Advance Affordable, AI-Based Orphan Drugs	Mike Ward	10/17/19	National
Alexion to Buy Achillion in $930M Marriage of Rare Disease Drug Firms	Frank Vinluan	10/16/19	Boston
Cyteir Adds $40M for Clinical Test of “Synthetically Lethal” Cancer Drug	Frank Vinluan	10/15/19	Boston
Vir Bio’s IPO Brings In $143M for Tests of Hepatitis B Drug and More	Frank Vinluan	10/11/19	San Francisco
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma	Frank Vinluan	10/10/19	Boston
Page 1 of 293	next page »